MeSH tree: D02.241.081.944.509
Women taking antiseizure medication for epilepsy have around a 45% reduced risk of major congenital anomalies in their children—if they initiate high-dose folic acid before pregnancy. This is the finding of a large Nordic ...
17 hours ago
0
5
Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by differences in how people interact or communicate with others, as well as restricted interests and repetitive patterns of behavior. Past studies ...
Findings published by The BMJ reinforce previous research linking use of the antiseizure drug valproate during pregnancy to neurodevelopmental disorders such as ADHD and autism in children, and indicate no substantial risk ...
Mar 11, 2026
0
13
Scientists are moving toward a genetic test that could help thousands of mothers with epilepsy safely take life-saving medication without fear of it causing birth defects in their children.
Feb 16, 2026
0
7
A new study in the lab of Jason Stein, Ph.D., modeled brain development in a dish to identify cells and genes that influence infant brain growth, a trait associated with autism.
Dec 23, 2025
0
35
The introduction of a stricter approval process for prescribing an anti-seizure drug that can cause birth defects when taken during pregnancy has been effective at reducing the number of prescriptions issued for the drug, ...
Dec 10, 2025
0
5
In a study carried out in collaboration with the World Health Organization, two Aston University academics have found that while access to antiseizure medication in low- and middle-income countries is growing, it is not necessarily ...
Nov 11, 2025
0
58
University of Mississippi researchers have developed a new tool to help scientists study how environmental and genetic factors interact to influence autism spectrum disorder.
Nov 11, 2025
0
20
A large-scale international study led by the University of Liverpool has found little evidence that sodium valproate significantly impairs male fertility in men with epilepsy or bipolar disorder.
Sep 15, 2025
0
17
A panel convened in July 2025 by the Food and Drug Administration sparked controversy by casting doubt about the safety of commonly used antidepressants during pregnancy. But it also raised the broader issue of how little ...
Aug 28, 2025
0
10
